Latest news
Is China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more - Endpoints NewsEndpoints News · Sat, 08 Aug 2026 10:00:00 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMTReplimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 20:03:00 GMTExclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 19:17:43 GMTSarepta pushes back Elevidys timeline; Emergent lays off 90 staffers - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 13:55:00 GMTVedanta gets $60M to finish Phase 3 for C. diff microbiome therapy - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 11:00:00 GMTGreg Verdine’s LifeMine raises $263M for safer immunosuppressant - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 10:30:00 GMT